Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This category represents therapeutic agents that do not interact with a specific protein receptor or enzyme but instead function through non-specific physical or chemical interactions with various substances. These agents include bile acid sequestrants, which bind bile acids in the gastrointestinal tract to interrupt enterohepatic circulation and lower cholesterol levels (StatPearls, 2023). Chelating agents, such as EDTA or penicillamine, work by forming stable, water-soluble complexes with heavy metals like lead or copper to facilitate their renal excretion (NIH, 2022). Additionally, adsorbents like activated charcoal are utilized in toxicology to bind a wide array of drugs and toxins within the gut lumen, preventing their systemic absorption (PubMed, 2021). Because these agents act via sequestration rather than traditional signal transduction, they are often used to treat metabolic disorders, poisoning, and mineral imbalances. However, their broad binding affinity can lead to significant therapeutic challenges, such as the malabsorption of essential nutrients and interference with the pharmacokinetics of other drugs. Consequently, these substances are defined by their ability to physically or chemically neutralize targets rather than by a specific biological site of action.
Binding and sequestration of target substances through physical adsorption, ion exchange, or chemical chelation to prevent systemic absorption or promote excretion.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-specific adsorbent and chelating agent.